OPKO Health, Inc. Accrued Income Taxes, Current
OPKO Health, Inc. (OPK) had Accrued Income Taxes, Current of $22.27 million as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2025-03-03
- 2024-12-31: Accrued Income Taxes, Current $22.27M.
- 2023-12-31: Accrued Income Taxes, Current $1.38M.
- 2022-12-31: Accrued Income Taxes, Current $5.35M.
- 2018-12-31: Accrued Income Taxes, Current $3.23M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2024-12-31 | $22.27M 10-K · filed 2025-03-03 |
| 2023-12-31 | $1.38M 10-K · filed 2025-03-03 |
| 2022-12-31 | $5.35M 10-K · filed 2024-03-01 |
| 2018-12-31 | $3.23M 10-K · filed 2019-03-01 |
| 2018-09-30 | $4.52M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $3.60M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.59M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $4.61M 10-K · filed 2019-03-01 |
| 2017-09-30 | $4.59M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $5.88M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.39M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $4.43M 8-K · filed 2019-01-29 |
| 2016-09-30 | $16.73M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $10.95M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $5.99M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $7.61M 10-K · filed 2017-03-01 |
| 2015-09-30 | $24.02M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $2.59M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $3.01M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $77.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | $325.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $406.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $124.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $702.00K 10-K · filed 2015-02-27 |
| 2013-09-30 | $3.23M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $2.42M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $1.79M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.61M 10-K · filed 2014-03-03 |
| 2012-09-30 | $649.00K 10-Q · filed 2012-11-09 |
| 2011-12-31 | $484.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |